American Journal of Ophthalmology
Volume 139, Issue 3 , Pages 405-420 , March 2005

Age-related macular degeneration 1969–2004: A 35-year personal perspective

  • Stuart L. Fine, MD

      Affiliations

    • Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
    • Corresponding Author InformationInquiries to Stuart L. Fine, MD, University of Pennsylvania, 51 North 39th Street, Philadelphia, PA 19104; fax: 215-662-9676

,Accepted 18 November 2004.

References 

  1. Gass JDM . Pathogenesis of disciform detachment of the neuroepithelium. IV. Fluorescein angiographic study of senile disciform macular degeneration . Am J Ophthalmol . 1967;63:617–645
  2. Leibowitz HM , Krueger DE , Maunder RA , et al.   The Framingham Eye Study monograph (an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975) . Surv Ophthalmol . 1980;24(suppl):335–610
  3. Hyman LG , Lilienfeld AM , Ferris FL , Fine SL , et al.   Senile macular degeneration (a case-control study) . Am J Epidemiol . 1983;118:213–227
  4. Bressler NM , et al.   The grading and prevalence of macular degeneration in Chesapeake Bay watermen . Arch Ophthalmol . 1989;107:847–852
  5. Klein R , et al.   The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity . Invest Ophthalmol Vis Sci . 1995;36:182–191
  6. Klein R , Klein BEK , Moss SE . Relation of smoking to the incidence of age-related maculopathy (the Beaver Dam Eye Study) . Am J Epidemiol . 1998;147:103–110
  7. Klein R , Klein BEK , Franke T . The relationship of cardiovascular disease and its risk factors to age-related maculopathy (the Beaver Dam Eye Study) . Ophthalmology . 1993;100:406–414
  8. Klein R , Klein BEK , Jensen SC . The relation of cardiovascular disease and its risk factors to the 5 year incidence of age-related maculopathy (the Beaver Dam Eye Study) . Ophthalmology . 1997;104:1804–1812
  9. Mitchell P , Smith W , Attebo K , Wang JJ , et al.   Prevalence of age-related maculopathy in Australia (the Blue Mountains Eye Study) . Ophthalmology . 1995;102: 2450-1460
  10. Vingerling JR , Hofman A , Diederick E , et al.   Age-related macular degeneration and smoking (the Rotterdam Study) . Arch Ophthalmol . 1996;114:1193–1196
  11. Vinding T , et al.   Risk factor analysis for atrophic and exudative age-related macular degeneration (an epidemiological study of 1000 aged individuals) . Acta Ophthalmol (Copenh) . 1992;70:66–72
  12. Eye Disease Case-Control Study Group . Risk factors for neovascular age-related macular degeneration . Arch Ophthalmol . 1992;110:1701–1708
  13. Eye Disease Case-Control Study Group . Risk factors for neovascular age-related macular degeneration . Arch Ophthalmol . 1992;110:1701–1708
  14. West SK , Rosenthal SF , Bressler NM , et al.   Exposure to sunlight and other risk factors for age-related macular degeneration . Arch Ophthalmol . 1989;107:875–879
  15. Seddon JM , Willett WC , Speizer FE , Hankinson SE , et al.   A prospective study of cigarette smoking and age-related macular degeneration in women . JAMA . 1996;276:1141–1146
  16. Christen WG , Glynn RJ , Manson JE , et al.   A prospective study of cigarette smoking and risk of age-related macular degeneration in men . JAMA . 1996;276:1147–1151
  17. Diabetic retinopathy Study Research Group . Preliminary report on effects of photocoagulation therapy . Am J Ophthalmol . 1976;81:383–396
  18. Patz A , Hoeck LE , De la Cruz E . Studies on the effect of high oxygen administration in retrolental fibroplasias. I. Nursery observations . Am J Ophthalmol . 1952;35:1248–1253
  19. Patz A . Oxygen studies in retrolental fibroplasias. IV. Clinical and experimental observations . Am J Ophthalmol . 1954;38:291–308
  20. Moorfields Macular Study Group . Treatment of senile disciform macular degeneration (a single-blind randomized trial by argon laser photocoagulation) . Brit. J Ophthalmol . 1982;66:745–753
  21. Coscas G , Soubrane G . Photocoagulation des neo vaisseaux sous-retiniens dans la degenerescence maculaire senile par laser a argon (resultants de letude randomisee de 60 cas) . Bull Mem Soc Fr Ophtalmol . 1982;94:149–154
  22. Macular Photocoagulation Study Group . Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial . Arch Ophthalmol . 1982;100:912–918
  23. Macular Photocoagulation Study Group . Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial . Arch Ophthalmol . 1990;108:816–824
  24. Schatz H , Yannuzzi LA , Gitter KA . Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy (complication or misdiagnosis?) . Trans Am Acad Ophthalmol Otolaryngol . 1977;83:893–906
  25. Ryan SJ . Subretinal neovascularization. Natural history of an experimental model . Arch Ophthalmol . 1982;100:1804–1809
  26. Yannuzzi LA , Slakter JS , Sorensen JA , Guyer DR , Orlock DA , et al.   Digital indocyanine green video-angiography of occult choroidal neovascularization . Retina . 1992;12:191–223
  27. Schuman JS , Puliafito CA , Fujimoto JG , et al.   Optical coherence tomography of ocular diseases . Thorofare: SLACK; 1996;
  28. Bird AC , Bressler NM , Bressler SM , et al.   An International ARM Epidemiology Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration . Survey Ophthalmol . 1995;39:367–374
  29. Macular Photocoagulation Study Group . Subfoveal neovascular lesions in age-related macular degeneration . Arch Ophthalmol . 1991;109:1242–1257
  30. Bressler SB , Bressler NM , Fine SL , et al.   Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration . Am J Ophthalmol . 1982;93:157–163
  31. Guyer DR , Fine SL , Maguire MG , Hawkins BS , Owens SL , Murphy RP . Subfoveal neovascular membranes in age-related macular degeneration (visual prognosis in eyes with relatively good initial visual acuity) . Arch Ophthalmol . 1986;104:702–705
  32. Macular Photocoagulation Study Group . Argon laser photocoagulation for neovascular maculopathy . Arch Ophthalmol . 1991;109:1109–1111
  33. Jampol LM . Hypertension and visual outcome in the Macula Photocoagulation Study . Arch Ophthalmol . 1991;109(6):789–790
  34. Macular Photocoagulation Study Group . Laser photocoagulation of subfoveal recurrent neovascular lesion in age-related macular degeneration. Results of randomized clinical trial . Arch Ophthalmol . 1991;109:1220–1231
  35. Macular Photocoagulation Study Group . Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial . Arch Ophthalmol . 1991;109:1232–1241
  36. Macular Photocoagulation Study Group . Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity . Arch Ophthalmol . 1994;112:480–488
  37. Strahlman ER , Fine SL , Hillis A . The second eye of patients with senile macular degeneration . Arch Ophthalmol . 1984;91:271–277
  38. Macular Photocoagulation Study Group . Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration . Arch Ophthalmol . 1997;115:741–747
  39. Smiddy WE , Fine SL . Prognosis of patients with bilateral macular drusen . Ophthalmology . 1984;91:271–277
  40. Holz FG , Wolfensberger TJ , Piguet B , et al.   Bilateral macular drusen in age-related macular degeneration . Ophthalmology . 1994;101:1522–1528
  41. D’Amato RJ , Loughnan MS , Flynn E , Folkman J . Thalidomide is an inhibitor of angiogenesis . Proc Natl Acad Sci USA . 1994;91:4082–4085
  42. Pharmacological Therapy for Macular Degeneration Study Group . Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial . Arch Ophthalmol . 1997;115:865–872
  43. Chakravarthy U , Gardiner TA , Archer DB , Maguire CJ . A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds . Current Eye Res . 1989;8:337–348
  44. Chakravarthy U , Houston RF , Archer DB . Treatment of age-related subfoveal neovascular membranes by teletherapy (a pilot study) . Br J Ophthalmol . 1993;77:261–262
  45. Radiation Therapy for Neovascular Age-Related Macular Degeneration Research Group . A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study) . Ophthalmology . 1999;106:2239–2247
  46. Fine SL , Maguire MG . It is not time to abandon radiotherapy for neovascular age-related macular degeneration . Arch Ophthalmol . 2001;119:275–276
  47. Age-Related Macular Degeneration and Radiotherapy Trial Research Group . The Age-related macular degeneration radiotherapy trial (AMDRT) (One year results from a pilot study) . Am J Ophthalmol . 2004;5:818–828
  48. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin . Arch Ophthalmol . 1999;117:1329–1345
  49. Miller JW , Schmidt-Erfurth U , Sickenberg M , et al.   Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration (results of a single treatment in a phase 1 and 2 study) . Arch Ophthalmol . 1999;117:1161–1173
  50. Schmidt-Erfurth U , Miller JW , Sickenberg M , et al.   Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration (results of retreatments in a phase 1 and 2 study) . Arch Ophthalmol . 1999;117:1177–1187
  51. Verteporfin in Photodynamic Therapy Study Group . Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration (two-year results of a randomized, clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2) . Am J Ophthalmol . 2001;131:541–560
  52. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Groups . Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration (TAP and VIP report No. 1) . Am J Ophthalmol . 2003;136:407–418
  53. Lanconey DM , Maguire MG , Fine SL . A model of incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration . Arch Ophthalmol . 1998;116:1045–1052
  54. Age-Related Eye Disease Study Research Group . AREDS Report #8. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss . Arch Ophthalmol . 2001;119:1417–1436
  55. Figueroa MS , Regueras A , Bertrand J . Laser photocoagulation to treat macular soft drusen in age-related macular degeneration . Retina . 1994;14:391–396
  56. Choroidal Neovascularization Prevention Trial Research Group . Laser treatment in eyes with large drusen (short term effects from a pilot randomized clinical trial) . Ophthalmology . 1998;105:11–23
  57. Choroidal Neovascularization Prevention Trial Research Group . Laser treatment in fellow eyes with large drusen (updated findings from a pilot randomized clinical trial) . Ophthalmology . 2003;110:971–978
  58. Kaiser RS , Berger JW , Maguire MG , Ho AC , Javornik NB  Choroidal Neovascularization Prevention Trial (CNVPT) Study Group . Laser burn intensity and the risk of choroidal neovascularization in the CMVPT Fellow Eye Study . Arch Ophthalmol . 2001;119:826–832
  59. Rodanant N , Friberg TR , Cheng L , et al.   Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration . Am J Ophthalmol . 2002;134:577–585
  60. Frennesson CI . Prophylactic laser treatment in early age-related macular degeneration (an 8-year follow-up in a randomized pilot study shows a reduced incidence of exudative complications) . Acta Ophthalmologica Scandinavica . 2003;81:449–454
  61. D’Amico DJ , Goldberg MF , Hudson H , et al.   Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration (twelve-month clinical outcomes) . Ophthalmology . 2003;110:2372–2383
  62. Submacular Surgery Trials Research Group . Surgery for subfoveal choroidal neovascularization in age-related macular degeneration (Ophthalmic findings) . SST Report No. 11. Ophthalmology . 2004;111:1967–1980
  63. Submacular Surgery Trials Research Group . Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings. SST Report No. 13 . Ophthalmology . 2004;111:1993–2006
  64. Hahn P , Milam AH , Dunaief JL . Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch’s membrane . Arch Ophthalmol . 2003;121:1099–1105
  65. Hahn P , Ying Q , Dentchev T , et al.   Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration . Proc Natl Acad Sci USA . 2004;101(38):13850–13855
  66. Chen L , Dentchev T , Wong R , Wen R , Bennett J , Dunaief JL . Increased expression of ceruloplasmin in the retina following photic injury . Mol Vis . 2003;30:151–158
  67. Johnson LV , Leitner WP , Rivest AJ , Staples MK , Radeke MJ , Anderson DH . The Alzheimer’s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration . Proc Natl Acad Sci USA . 2002;99:11830–11835
  68. Dentchev T , Milam AH , Lee VM , Trojanowski JQ , Dunaief JL . Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas . Mol Vis . 2003;14:9184–9190
  69. The Eye Disease Prevalence Research Group . Causes and prevalence of visual impairment among adults in the United States . Arch Ophthalmol . 2004;122:477–485
  70. Incidence of age-related macular degeneration among elderly Americans . Ophthalmology . 2003;110:1534–1539

 Supported, in part, by Research to Prevent Blindness, Inc., New York, New York, National Eye Institute grant No. U10-EY-012261, (Complications of AMD Prevention Trial), the Paul Mackall and Evanina Evans Bell Mackall Trust, the Scheie Eye Institute Macular Degeneration Research Fund, the F.M. Kirby Foundation, and the Rosanne Silbermann Foundation.

PII: S0002-9394(04)01413-8

doi: 10.1016/j.ajo.2004.11.050

American Journal of Ophthalmology
Volume 139, Issue 3 , Pages 405-420 , March 2005

Article Tools

* Image Usage & Resolution